F mice with aGVHD [32]. In order for human MSC cell therapy
F mice with aGVHD . In order for human MSC cell therapy to become useful at day 0, MSC necessary stimulation or activation with IFNg (Fig. 1). These final results…
F mice with aGVHD . In order for human MSC cell therapy to become useful at day 0, MSC necessary stimulation or activation with IFNg (Fig. 1). These final results…